New drugs may hold the key to melanoma treatment
By Catholic Online (NEWS CONSORTIUM)
6/3/2014 (2 years ago)
Catholic Online (www.catholic.org)
Two new drugs may provide an exciting and striking treatment option for those who suffer from advanced cases of melanoma.
Image scans of Steele's lungs before and after his treatment. The left scan shows numerous gray colored cancer tissues, which are gone in the right, after his treatment.
LOS ANGELES, CA (Catholic Online) - In separate international trials, new drugs pembrolizumab and nivolumab, have seen great success treating melanoma, which is the most dangerous type of skin cancer, and also causes the most amount of deaths of any skin disease. When melanoma spreads to other organs it is very difficult to treat, and, until a few years ago, average survival was around half a year.
Both drugs are designed to help the immune system recognize and target cancerous cells by blocking the biological pathway the cancers use to disguise themselves from the immune system.
Pembrolizumab, formerly known as MK-3475, was tested on 411 patients, of which 69% survived for at least one year. This drug is also being tested on cancers which utilize a similar method to block attacks from the immune system.
"Pembrolizumab looks like it has potential to be a paradigm shift for cancer therapy," said Dr. David Chao, consultant oncologist at the Royal Free London NHS Foundation Trust. Chao is conducting trials on melanoma and lung cancer patients.
64-year-old Warwick Steele has been receiving infusions of the drug every three weeks since October, and has seen phenomenal results.
"I got tired simply standing up and was literally too exhausted to shave. But now I feel back to normal and can do gardening and go shopping," he said.
Prior to his treatment, Steele could barely walk because the cancers in his lungs made it hard to breath. Scans have shown that just after three infusions, the cancer seems to have been totally cleared out of his lungs.
Nivolumab, which was tested in conjunction with the existing immunotherapy ipilimumab, saw 85% of its' 53 patients survive past a year, and 79% after two years.
Copyright 2017 - Distributed by THE CALIFORNIA NETWORK
Pope Francis Prayer Intentions for APRIL 2017
Young People. That young people may respond generously to their vocations and seriously consider offering themselves to God in the priesthood or consecrated life.
A new Stanford study revealed what many believe could be the first step to a true cure for aging. LOS ANGELES, CA (Catholic Online) - The ... continue reading
Scientists believe an extremely high dose of one vitamin may be the cure for cancer. LOS ANGELES, CA (Catholic Online) - There have been ... continue reading
If you are afraid of cancer, we have bad news. There may be little way to avoid the dreaded disease. A new study affirms that two-thirds of ... continue reading
Supreme Court nominee Neil Gorsuch made a crucial ethical distinction in his response to questions about doctor-prescribed suicide during ... continue reading
'Three-parent babies' are coming. We are resistant to wisdom, let's pray we are resistant to the consequences Watch
British doctors have been given the OK to create embryos from three parents to prevent genetic diseases. The first such child could be born ... continue reading
by Catholic Online
- St. Catherine of Siena: Saint of the Day for Saturday, April 29, 2017
- Pope Francis arrives in Egypt with powerful message HD Video
- Report claims extreme weather on DECLINE - but is someone lying?
- Daily Reading for Tuesday, May 2nd, 2017 HD Video
- Daily Readings for Saturday, April 29, 2017
- It feels great to win! Here's the list of things President Trump has ...
- 'Acid is now a fashionable weapon of choice' - Britain averages one ...
- Daily Reading for Monday, May 1st, 2017 HD
- Daily Reading for Sunday, April 30th, 2017 HD
- Day 9 - Novena for Workers, the Unemployed and Underemployed HD
- Day 8 - Novena for Workers, the Unemployed and Underemployed HD
Copyright 2017 Catholic Online. All materials contained on this site, whether written, audible or visual are the exclusive property of Catholic Online and are protected under U.S. and International copyright laws, © Copyright 2017 Catholic Online. Any unauthorized use, without prior written consent of Catholic Online is strictly forbidden and prohibited.